6 April 2017 - PhRMA lobby’s ad campaign targets insurers over rebates.
New punches were thrown in the blame game over U.S. drug prices Thursday.
Broadening its efforts to defuse outrage over skyrocketing prices, Pharmaceutical Research and Manufacturers of America, the industry’s lobbying association, started an advertising campaign urging insurers to share with customers more of the benefits of rebates they’ve negotiated. In response, the main health-insurance lobby pushed the blame back on drug makers: “Enough with the distractions.”
Meanwhile, the head of one of the largest pharmacy benefit managers, who are often criticised by drug makers for their lack of transparency, said his industry helps save money and manufacturers should stop faulting the middlemen.